|Title:||Inflammatory disease treatment|
|Abstract:||A method treating virus-induced and inflammatory diseases of skin and membranes in humans or animals, comprising application of a composition consisting of one or more of the aliphatic alcohols docosanol, tetracosanol and hexacosanol in a physiologically compatible carrier is disclosed.|
|Inventor(s):||Katz; David H. (La Jolla, CA)|
|Assignee:||Lidak Biopharmaceuticals (La Jolla, CA)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0428642||May 29, 1991||57/2007||Austria||<disabled>|
|Japan||3064009||Jul 12, 2000|
|European Patent Office||0428642||May 29, 1991||300354||Netherlands||<disabled>|
|European Patent Office||0428642||Sep 29, 1993||300354||Netherlands||<disabled>|
|European Patent Office||0428642||Sep 29, 1993||57/2007||Austria||<disabled>|
|This preview shows a limited data set|
Subscribe for full access
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.